The GLOW Study: GLP-1 and Lifestyle for Optimal Wellness

The goal of this clinical trial is to learn whether a 30-day structured wellness program may support physical and emotional well-being in adults who are already taking a GLP-1 or dual GIP/GLP-1 medication for an FDA-approved indication. The study does not evaluate the GLP-1 medication itself or make changes to participants' medication treatment.

The main questions it aims to answer are:

1. Are there changes in participants' physical and emotional well-being after completing the 30-day wellness program?
2. Are there changes in areas such as mood, anxiety, functioning, mindfulness, self-compassion, eating-related behaviors, pain, and positive wellness?

Participants will:

1. Complete online questionnaires before and after the program.
2. Follow the WILD 5 Wellness program for 30 days, which includes daily practices related to exercise, mindfulness, sleep, social connection, and nutrition.
3. Complete a brief online tracking form each day during the 30-day program.